Deloitte Insights Podcast

Life Sciences and Emerging Markets: Know Your Risk

07.26.2011 - By Deloitte LLPPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

With a global market that is exceeding 1 trillion dollars and projections over the next five years of double digit growth, it is an exciting time for life sciences companies. Emerging markets provide attractive growth opportunities for life sciences companies. But life sciences companies should proceed with caution. While emerging markets may represent incredible growth opportunities, they are still developing, and many have reputations for seemingly pervasive corruption in their business practices and processes. It is critical for companies to know the risks to effectively capitalize on opportunities for growth.

More episodes from Deloitte Insights Podcast